Back in February 2023, state pharmaceutical firm PT Kimia Farma Tbk (KAEF) signed an investment agreement with Indonesia Investment Authority/INA (which has now part of sovereign wealth fund Danantara) and China-based Silk Road Fund (SRF) to boost retail subsidiary PT Kimia Farma Apotek (KFA). To subscribe please click here
